Paraoxonase-1 Is Not Associated with Coronary Artery Calcification in Type 2 Diabetes: Results from the PREDICT Study
Objectives: To determine any association between serum paraoxonase-1 (PON1) activity, protein and coding region genetic polymorphisms and coronary artery calcification (CACS) and to determine factors which modulate serum PON1 in type 2 diabetes (T2DM).
Main Authors: | Bharti Mackness, Judit Marsillach, Robert S. Elkeles, Ian F. Godsland, Michael D. Feher, Michael B. Rubens, Marcus D. Flather, Steve E. Humphries, Jackie Cooper, Mike Mackness |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.3233/DMA-2012-0910 |
Similar Items
-
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
by: Mackness Michael, et al.
Published: (2009-01-01) -
Paraoxonase-1 and -3 Protein Expression in the Brain of the Tg2576 Mouse Model of Alzheimer’s Disease
by: Jose Gregorio Salazar, et al.
Published: (2021-02-01) -
Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment
by: Joven Jorge, et al.
Published: (2010-05-01) -
Paraoxonase-1 Inhibits Oxidized Low-Density Lipoprotein-Induced Metabolic Alterations and Apoptosis in Endothelial Cells: A Nondirected Metabolomic Study
by: Anabel García-Heredia, et al.
Published: (2013-01-01) -
Paraoxonase-1 status in patients with hereditary hemochromatosis
by: Nicola Martinelli, et al.
Published: (2013-05-01)